Homozygous deletion of MAP2K4 is often accompanied by mutations of TP53 (encoding major tumor suppressor p53) and KRAS (encoding common tumor promoter K-Ras) in lung adenocarcinomas [62]. This evidence concerns the gene TP53 and lung adenocarcinoma.